Endothelin-1 from prostate cancer cells is enhanced by bone contact which blocks osteoclastic bone resorption

Br J Cancer. 2000 Aug;83(3):360-5. doi: 10.1054/bjoc.2000.1261.

Abstract

The causes for the propensity of metastasized prostate cancer cells to grow in bone and to induce osteoblastic lesions remain unresolved. Co-culture of human prostate cancer cell lines with bone slices was determined to increase the level of endothelin-1 (ET-1) mRNA and its production. ET-1 is an ejaculate protein that also stimulates osteoblasts. Osteoclastic bone resorption was significantly blocked by the presence of androgen-independent prostate cancer cells in a dose-dependent manner as that of synthetic ET-1. The inhibition could be neutralized by specific ET-1 antibody, indicating the association of prostate cancer-derived ET-1 with inhibition of bone resorption. The combined ET-1 activity on osteoclasts and osteoblasts disrupts bone remodelling. ET-1 production is also elevated in the presence of prostate-specific antigen (PSA). ET-1 in turn enhances DNA synthesis of prostate cancer cells. Interactions among cancer cells, bone, ET-1 and PSA may be critical in cancer growth and lesions in bone.

MeSH terms

  • Analysis of Variance
  • Blotting, Northern
  • Bone Resorption / etiology*
  • Bone Resorption / metabolism*
  • Bone and Bones / metabolism*
  • Cell Division
  • Endothelin-1 / genetics
  • Endothelin-1 / metabolism*
  • Humans
  • Male
  • Osteoblasts / metabolism
  • Osteoclasts / metabolism
  • Prostate-Specific Antigen / metabolism
  • Prostatic Neoplasms / complications*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Tumor Cells, Cultured

Substances

  • Endothelin-1
  • Prostate-Specific Antigen